Tempest Therapeutics Inc. Gains 33.71%
Wed, Mar 29, 2023 at 07:03 PM
Tempest Therapeutics Inc. (TPST:NASDAQ) soared at $2.34, representing a gain of 33.7%. On Wed, Mar 29, 2023, TPST:NASDAQ hit a New 2-Week High of $2.34. The stock appeared on our News Catalysts scanner on Wed, Mar 22, 2023 at 06:58 PM in the 'INVESTOR UPDATE' category. From Wed, Mar 15, 2023, the stock recorded 70.00% Up Days and 54.55% Green Days
About Tempest Therapeutics Inc. (TPST:NASDAQ)
Tempest Therapeutics Inc is a clinical-stage biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific...
Top 10 Gainers:
- Troika Media Group Inc. (TRKA:NASDAQ), 49.5%
- Local Bounti Corporation (LOCL:NYSE), 46.86%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 42.33%
- LogicMark Inc Com Par$ (New) (LGMK:NASDAQ), 39.29%
- Nexters Inc. (GDEV:NASDAQ), 38.35%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 37.5%
- CBL International Limited (BANL:NASDAQ), 35.24%
- E-Home Household Service Holdings Limited (EJH:NASDAQ), 34.45%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 33.71%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 32.61%